Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenylethylamine in paranoid chronic schizophrenia.

S G Potkin, F Karoum, L W Chuang

    Science (New York, N.Y.)
    |October 26, 1979
    PubMed
    Summary

    Phenylethylamine (PEA), an endogenous amine, was found in higher urinary concentrations in paranoid chronic schizophrenics. This suggests PEA may function as an endogenous amphetamine in schizophrenia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of phenylalanine hydroxylating activity in vivo : (18)O-tyrosine in plasma after exposing rats to(18)O 2.

    Neurochemical research·2013
    Same author

    Localization of gliosis in the corpus striatum of mice following cortical lesions.

    Restorative neurology and neuroscience·2011
    Same author

    Exposure of a 'witness rat' to one treated with beta-carboline FG 7142 does not increase dopamine turnover in the medial prefrontal cortex of the 'witness rat'.

    Neuroscience letters·2001
    Same author

    SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine.

    Behavioural pharmacology·2000
    Same author

    Effects of the administration of amphetamine, either alone or in combination with reserpine or cocaine, on regional brain beta-phenylethylamine and dopamine release.

    American journal of therapeutics·1999
    Same author

    GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat.

    Journal of neurochemistry·1999

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Biochemistry

    Background:

    • Phenylethylamine (PEA) is an endogenous amine with structural and pharmacological similarities to amphetamine.
    • Altered neurotransmitter systems are implicated in the pathophysiology of schizophrenia.

    Purpose of the Study:

    • To investigate urinary phenylethylamine (PEA) excretion in patients with chronic schizophrenia compared to controls.
    • To explore the potential role of PEA as an endogenous amphetamine in schizophrenia.

    Main Methods:

    • Urinary PEA levels were measured in three groups: paranoid chronic schizophrenics, nonparanoid chronic schizophrenics, and normal controls.
    • Factors such as diet, hospitalization status, and medication were considered as potential confounders.

    Main Results:

    • Urinary PEA excretion was significantly elevated in paranoid chronic schizophrenics compared to both nonparanoid chronic schizophrenics and normal controls.
    • No significant differences in PEA concentrations were found that could be attributed to diet, hospitalization, or medication.

    Conclusions:

    • The elevated urinary PEA levels in paranoid chronic schizophrenics suggest a potential link between PEA and the paranoid subtype of schizophrenia.
    • These findings support the hypothesis that phenylethylamine (PEA) may act as an endogenous amphetamine in certain psychiatric conditions.

    Related Experiment Videos